Federal regulators will no longer require patients to provide blood tests before receiving the drug from pharmacies. Federal regulators will no longer require patients to provide blood tests before receiving the drug from pharmacies. Regulation and Deregulation of Industry, Tests (Medical), Schizophrenia, Drugs (Pharmaceuticals), Mental Health and Disorders, Food and Drug Administration, United States, your-feed-science, your-feed-healthcare, Clozapine NYT > Science
F.D.A. Expands Access to Clozapine, a Key Treatment for Schizophrenia
